On the aspect of antigenicity, the RBD, S1 and S proteins reacted well with the convalescent sera, suggesting that these proteins maintain the native-like SARS-CoV-2 epitopes that are immunogenic in COVID-19 patients. The gene discussed is PSMD1; the disease is COVID-19.